Clover Health Investments, Corp. (CLOV) fair value analysis
Nasdaq · Updated 2026-09-07
Clover Health Investments, Corp. is a healthcare company that provides Medicare Advantage insurance plans to seniors. The company operates primarily in the United States, offering coverage and related services to eligible beneficiaries across multiple states.
Valuation status
Awaiting full valuationCLOV does not yet have sufficient validated earnings history for a full Forward Fair Value verdict under our standards — we require at least six validated trailing price-to-earnings windows before publishing one. TickrTrends re-evaluates every covered stock weekly; a verdict publishes automatically once enough validated history accumulates.
- Last price
- $4.33
- Sector
- Healthcare
- 12-month range
- $1.70–$5.39
Derived indicators
Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.
- Quality grade
- D
- Leverage
- Low
- RSI zone
- Neutral
- 50/200-day trend
- Uptrend
- 52-week position
- The upper-middle quarter of its range
What our data shows for CLOV
- Shares are trading in the upper third of their 12-month price range of $1.70–$5.39.
- The 14-day relative strength index sits at a neutral 53.
The exact numbers are one step away
- The precise Forward Fair Value dollar figure for CLOV
- Exact discount / premium to today's price
- The normalized historical P/E behind the estimate, and how many quarters support it
- Forward EPS input and fiscal-year basis
- Screeners and rankings across the full S&P 500 and Nasdaq universes
How Forward Fair Value works
TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.
Recent CLOV news
TickrTrends' derived news-sentiment signal for CLOV is currently mixed, computed from recent coverage.
- Clover Health (CLOV) Turns Profitable As Medicare Membership Explodes (insidermonkey.com, 2026-09-03)
TickrTrends take: Clover Health's achievement of profitability coupled with significant Medicare membership growth represents a fundamental operational improvement that valuation analysts will need to incorporate into their models. TickrTrends is currently awaiting full valuation for CLOV, meaning investors should monitor how this profitability milestone and membership expansion translate into updated financial metrics and earnings guidance. For a Healthcare sector company like Clover Health, the combination of growing membership and achieving profitability provides clearer data points that could inform the company's eventual valuation assessment. - Clover Health to Participate in Upcoming Investor Conferences (manilatimes.net, 2026-08-31)
TickrTrends take: Clover Health's participation in upcoming investor conferences provides an opportunity for the market to hear directly from management about the company's operational performance and strategic direction, which will be relevant as TickrTrends awaits sufficient data to complete its full valuation analysis. For investors focused on valuation metrics, these conference appearances may generate insights into the company's competitive positioning within the Healthcare sector and its path to profitability. The information disclosed during these events could help inform the comprehensive valuation assessment currently pending for CLOV. - Clover Health Is A 'Buy' Because Of Its AI (NASDAQ:CLOV) (seekingalpha.com, 2026-08-26)
TickrTrends take: Clover Health operates in the Healthcare sector where artificial intelligence applications are increasingly relevant to competitive positioning and operational efficiency. The company's current TickrTrends valuation status remains awaiting full valuation, meaning investors do not yet have a comprehensive assessment of how AI capabilities should factor into its fundamental value. Valuation-focused readers should monitor how the market incorporates AI developments into CLOV's earnings multiples and whether operational improvements from these technologies translate into measurable financial metrics.
What people are saying
Follow the CLOV conversation: Stocktwits · Reddit · X
TickrTrends weekly updates
- 2026-09-07 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-06 — No material change this week: the verdict, bands and grades all held steady.
- 2026-08-31 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.
Frequently asked questions
Is CLOV stock undervalued?
CLOV does not yet have sufficient validated earnings history for a full Forward Fair Value verdict under TickrTrends' standards; it is re-evaluated every week.
What is CLOV's TickrTrends verdict?
CLOV is currently marked 'Awaiting full valuation' - a verdict publishes automatically once at least six validated trailing P/E windows accumulate.
Is CLOV overbought or oversold?
CLOV's 14-day RSI is in neutral territory - neither overbought nor oversold.